Key Takeaway: The 48-hour rule is the safety floor for semaglutide injections
There is no formulary negotiation
HCPCS code J1815 is the code for injection, insulin, per 5 units used to report insulin by the number of units administered rather than by vial or dose
People with pre-existing digestive disorders, a history of gastric surgery, or those already experiencing mild digestive symptoms should discuss these concerns with their healthcare provider before starting treatment
Potential benefits of GLP-1 for type 1 diabetes can include weight loss, reduced appetite, lower post-meal glucose excursions, and possibly less insulin requirement in some people
Who is generally a candidate Adults 18 and older with a BMI of 30 or higher (obesity), or Adults with a BMI of 27 or higher plus at least one weight-related condition: type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea No disqualifying personal or family medical history (see below) Willing to attend an in-person evaluation and follow-up visits during titration Who we generally do not prescribe to Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (multiple endocrine neoplasia type 2) History of pancreatitis Severe gastroparesis or other significant gastrointestinal motility disease Pregnancy , breastfeeding, or actively planning pregnancy An active eating disorder Known hypersensitivity to semaglutide, tirzepatide, or a formulation's inactive ingredients We also look at what else is driving your case before deciding a GLP-1 is the right tool
